Related Experiment Video

Updated: Aug 17, 2026

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques
11:28

Dried Blood Spots - Preparing and Processing for Use in Immunoassays and in Molecular Techniques

Published on: March 13, 2015

40.8K

[Prevalence of viral hepatitis type C in blood donors in Peru 2016 - 2017]

Alvaro Bellido1, Enrique Argumanis2, Patricia Segura3

  • 1Servicio de Gastroenterología, Hospital Cayetano Heredia. Lima, Perú; Universidad Peruana Cayetano Heredia. Lima, Perú.

Revista De Gastroenterologia Del Peru : Organo Oficial De La Sociedad De Gastroenterologia Del Peru
|January 3, 2022
PubMed

Insights

Hepatitis C virus (HCV) infection prevalence in Peruvian blood donors was 0.428% in 2016 and 0.301% in 2017. Updated data is crucial for effective treatment and reducing HCV infection rates by 2030.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Public Health

Background:

  • Hepatitis C virus (HCV) infection is a significant global health concern.
  • Recent advancements in direct-acting antivirals offer high sustained viral response rates.
  • Accurate prevalence data is essential for effective public health strategies.

Purpose of the Study:

  • To determine the current prevalence of HCV infection among blood donors in Peru.
  • To provide updated epidemiological data for national health planning.
  • To support efforts in achieving the WHO's 2030 HCV reduction targets.

Main Methods:

  • Descriptive epidemiological study.
  • Analysis of anti-HCV antibody detection data from national blood banks.
  • Data sourced from the National Blood Transfusion and Blood Banks Program (PRONAHEBAS) in Peru.

Main Results:

  • The prevalence of anti-HCV antibodies in Peruvian blood donors was 0.428% in 2016.
  • The prevalence decreased to 0.301% in 2017.
  • These findings represent the national seroprevalence in the studied period.

Conclusions:

  • Updated prevalence data on HCV infection is vital for public health interventions.
  • Understanding current infection rates is the first step toward disease treatment and control.
  • This study contributes essential data to combatting the HCV epidemic in Peru.
Abstract

More Related Videos

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

9.9K
Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

3.9K

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...